A. Morrison-Porter

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

William T. Hu, M. Diamond, J. Crowe, 2020, Nature Immunology.

Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection

Hao Wu, Monica Cabrera-Mora, I. Sanz, 2020, bioRxiv.

Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma

F. E. Lee, M. Woodruff, M. Runnstrom, 2022, American journal of respiratory and critical care medicine.

Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation

W. Chen, I. Sanz, S. Kyu, 2020, medRxiv.

Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection

P. Cravedi, J. Maltzman, E. Akalin, 2021, Journal of the American Society of Nephrology : JASN.

Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes

William T. Hu, I. Sanz, S. Kyu, 2020 .

Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment

R. Antia, W. Chen, I. Sanz, 2023, medRxiv.

One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses

Henry M. Wu, H. Chu, I. Sanz, 2021, ImmunoHorizons.

The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination

S. Lonial, Doan C. Nguyen, N. Haddad, 2024, medRxiv.